M&R Capital Management’s Novavax NVAX Stock Holding History

M&R Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-135	Closed	-$2K	–	619
2022 Q3	$2K	Hold	135	–	–	﹤0.01%	412
2022 Q2	$6K	Hold	135	–	–	﹤0.01%	371
2022 Q1	$9K	Hold	135	–	–	﹤0.01%	341
2021 Q4	$19K	Hold	135	–	–	﹤0.01%	303
2021 Q3	$27K	Hold	135	–	–	0.01%	279
2021 Q2	$28K	Hold	135	–	–	0.01%	283
2021 Q1	$24K	Hold	135	–	–	0.01%	278
2020 Q4	$15K	Buy	135 +15	+13%	+$1.59K	﹤0.01%	324
2020 Q3	$13K	Buy	120 +20	+20%	+$2.44K	﹤0.01%	340
2020 Q2	$8K	Buy	+100	New	+$3.83K	﹤0.01%	372

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIG

Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

M&R Capital Management's NVAX Position: Q4 2022 in Review

M&R Capital Management sold out of Novavax (NVAX) in Q4 2022, closing a stake of 135 shares — an estimated $2K sold.

M&R Capital Management first reported a position in NVAX in Q2 2020 and held it in 10 quarters. The position peaked at $28K in Q2 2021. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

M&R Capital Management reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
M&R Capital Management sold 135 Novavax shares in Q4 2022, an estimated $2K.
M&R Capital Management first reported a position in Novavax in Q2 2020 and held it in 10 quarters.
M&R Capital Management's Novavax position peaked at $28K in Q2 2021.
252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on M&R Capital Management's 13F filing for Q4 2022, filed 11 Jan 2023.